Summary. Cardiovascular responses to graded iv infusions of norepinephrine were observed in 24 dogs that had been treated for 1 week with either placebo, dexamethasone, or deoxycorticosterone. Eight dogs served as control and received daily iv injections of placebo; eight dogs received the mineralocorticoid, deoxycorticosterone; and eight received the glucocorticoid, dexamethasone. The three groups did not differ with respect to base-line hemodynamic variables either before administration of norepinephrine or after autonomic reflexes had been inhibited by ganglionic blockade. Comparisons of the three groups' hemodynamic responses to norepinephrine were made both before and after ganglionic blockade with the parallel line bioassay as a statistical test.
The effects of control, deoxycorticosterone, and dexamethasone treatments on body weight and hematocrit were compared with analysis of variance (7) . Analysis of variance also was used to compare the effects of these treatments on mean arterial pressure, cardiac output, mean right atrial pressure, total peripheral vascular resistance, heart rate, and stroke volume after anesthesia but before administration of norepinephrine (7) . The effects of the three treatments on responses to norepinephrine (defined as the differences between observations made before and those made during norepinephrine infu-I The preservatives in the brand of heparin employed in these experiments do not interfere with optical characteristics of indocyanine green dye (5). sions) were compared with a parallel line bioassay as a statistical test (8) .
Results

Body weight and hematocrit
Small decreases in body weight were noted during the week of treatment. The decreases were similar in the three groups. Hematocrit did not change significantly.
Base-line hemodynamic observations (Tables I  and II) Observations were made on arterial and right atrial pressures, cardiac output, and heart rate before norepinephrine was infused. There were no significant differences among the three groups of dogs with respect to the base-line levels of these observed hemodynamic variables or the calculated values for base-line levels of derived variables. Administration of hexamethonium caused significant reductions in base-line values for mean arterial pressure, cardiac output, and stroke volume; there were significant increases in heart rate but no significant changes in peripheral resistance or right atrial pressure. Again there were no significant differences among the three groups with respect to these base-line levels.
Responses to norepinephrine (Tables III and IV Comparisons between animals given deoxycorticosterone and animals given dexamethasone. Before hexamethonium the responses to norepinephrine in dogs treated with deoxycorticosterone did not differ significantly from responses in dogs given dexamethasone.
After administration of hexamethonium, increases in mean arterial pressure and peripheral resistance were greater in animals given deoxycorticosterone. Increases in mean right atrial pressure were greater in animals given dexamethasone. The two groups did not differ significantly with respect to changes in cardiac output, heart rate, or stroke volume. It should be pointed out, however, that increases in cardiac output in dogs given dexamethasone exceeded the increases in dogs given deoxycorticosterone by a margin that bordered on significance.
Discussion
Deoxycorticosterone has a pronounced effect on electrolyte metabolism and almost no effect on carbohydrate metabolism. In contrast, dexamethasone has virtually no effect on electrolyte metabolism and a very potent effect on carbohydrate metabolism (9) . The doses of these two steroids were chosen so that mineralocorticoid effects of deoxycorticosterone and glucocorticoid effects of dexamethasone were equivalent to corresponding effects of 0.3 mg per day of 9a-fluorohydrocortisone in a human subject of average size (9) . Subjects given this dose of 9a-fluorohydrocortisone for 1 week had augmented forearm vascular responses to norepinephrine (10) . The three groups of dogs did not differ signifi-relationship between calculated peripheral vascucantly with respect to their base-line hemodynamic lar resistance and mean arterial pressure during variables or their responses to ganglionic blockade. administration of norepinephrine. These animals The altered responses to norepinephrine, there-had greater increases in resistance, i.e., greater fore, cannot be attributed to differences in base-vasoconstriction, against greater increases in line vasomotor activity.
transmural pressure than did either control dogs Data from the experiment reported here in-or dogs given dexamethasone. The vascular efdicate that dogs given deoxycorticosterone had fects of norepinephrine also were augmented in greatly augmented vascular responses to norepi-dogs given dexamethasone because the vasoconnephrine. This was deduced from changes in the striction was similar to that in control dogs Figure 1 . Before Ce, cardiac output did not change with administration of norepinephrine; the requirements for the bioassay were not satisfied and relative potency was not calculated. Note that the limits for relative potency in the panels for heart rate are inverted. Thus, before C8, dogs given deoxycorticosterone had the greatest cardiac slowing in response to norepinephrine. whereas transmural pressure was greater. The magnitude of the augmentation, however, was much less than that seen with deoxycorticosterone. These results suggest that the mineralocorticoid activity of 9a-fluorohydrocortisone was primarily responsible for augmenting vascular responses to norepinephrine in the earlier experiments (10) .
It has been suggested that mineralocorticoids cause intracellular accumulation of sodium and depletion of potassium, reducing transcellular gradients for these cations (11) (12) (13) (14) . Reductions in these gradients are thought to be associated with augmented responsiveness to contractile stimuli (14) (15) (16) .
Dexamethasone was associated with slight potentiation of the vascular effects of norepinephrine and did not block these effects as some observers have suggested (17) . It These results in animals given dexamethasone are consistent with results from in vitro experiments in which spiral strips of rabbit aorta responded to norepinephrine with larger contractions when glucocorticoids were added to the bath (18) . The reasons for this potentiation remain conjectural.
Before hexamethonium norepinephrine produced decreases in heart rate that were greater in dogs treated with deoxycorticosterone than in dogs treated with placebo. This probably was the result of greater increases in mean arterial pressure causing greater stimulation of baroreceptor reflexes.
After hexamethonium norepinephrine caused bradycardia in all three groups of dogs. The bradycardia was directly related to increases in blood pressure, suggesting incomplete vagal blockade by hexamethonium. Vagal ganglia are reported to be the least sensitive of all autonomic ganglia to the blocking action of hexamethonium (19) . It is interesting that, after hexamethonium, heart rate decreased more in dogs treated with deoxycorticosterone than in dogs treated with placebo. This probably occurred because the enhanced pressor response caused greater stimulation of incompletely blocked baroreceptor reflexes. The bradycardia caused by norepinephrine after hexamethonium in dogs given dexamethasone is more difficult to explain because decreases in heart rate were proportionately greater than increases in mean arterial pressure. It is possible that dexamethasone potentiated the reflex effects of norepinephrine. It is also possible that greater increments in stroke volume provided a greater stimulus to the baroreceptors.
Before hexamethonium norepinephrine produced increases in mean right atrial pressure that were greater in animals treated with deoxycorticosterone and dexamethasone than in control animals. These enhanced responses could have resulted from greater venoconstriction with norepinephrine or from normal venoconstriction in the presence of a greater blood volume (20, 21) . De- oxycorticosterone augmented arterial responses to norepinephrine; it might be expected to have a similar effect on venous responses. It is interesting that forearm venous responses to norepinephrine are potentiated by treatment with 9a-fluorohydrocortisone (22) and that increases in blood volume occur with administration of glucocorticoids (23) .
After hexamethonium the effects of norepinephrine on mean right atrial pressure were greater in dogs treated with dexamethasone than in control dogs, but not greater in animals treated with deoxycorticosterone. In the latter group, preceding infusions of norepinephrine may have caused relatively greater constriction in postcapillary than in precapillary resistance vessels (24, 25) . This could have led to greater capillary filtration, a reduction in intravascular volume, and a diminished response of right atrial pressure. The constrictor effect of norepinephrine on postcapillary resistance vessels probably was less pronounced in dogs treated with dexamethasone. In these animals the primary factor responsible for a greater increase in mean right atrial pressure could have been a greater blood volume.
